HB-202
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HB-202, covering 2025-06-22 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC) [EARLY_Phase 1]